These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35094937)

  • 1. Regenerative effect of expired platelet concentrates in human therapy: An update.
    Burnouf T; Goubran HA
    Transfus Apher Sci; 2022 Feb; 61(1):103363. PubMed ID: 35094937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery.
    Burnouf T; Chou ML; Lundy DJ; Chuang EY; Tseng CL; Goubran H
    J Biomed Sci; 2023 Sep; 30(1):79. PubMed ID: 37704991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells.
    Jonsdottir-Buch SM; Lieder R; Sigurjonsson OE
    PLoS One; 2013; 8(7):e68984. PubMed ID: 23874839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering.
    Shanbhag S; Mohamed-Ahmed S; Lunde THF; Suliman S; Bolstad AI; Hervig T; Mustafa K
    Stem Cell Res Ther; 2020 Sep; 11(1):351. PubMed ID: 32962723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amotosalen treatment on human platelet lysate bioactivity: A proof-of-concept study.
    Christensen C; Jonsdottir-Buch SM; Sigurjonsson OE
    PLoS One; 2020; 15(4):e0220163. PubMed ID: 32294080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifaceted regenerative lives of expired platelets in the second decade of the 21st century.
    Burnouf T; Goubran HA; Seghatchian J
    Transfus Apher Sci; 2014 Oct; 51(2):107-12. PubMed ID: 25189105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expired and Pathogen-Inactivated Platelet Concentrates Support Differentiation and Immunomodulation of Mesenchymal Stromal Cells in Culture.
    Jonsdottir-Buch SM; Sigurgrimsdottir H; Lieder R; Sigurjonsson OE
    Cell Transplant; 2015; 24(8):1545-54. PubMed ID: 25198449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming the bottleneck of platelet lysate supply in large-scale clinical expansion of adipose-derived stem cells: A comparison of fresh versus three types of platelet lysates from outdated buffy coat-derived platelet concentrates.
    Glovinski PV; Herly M; Mathiasen AB; Svalgaard JD; Borup R; Talman MM; Elberg JJ; Kølle ST; Drzewiecki KT; Fischer-Nielsen A
    Cytotherapy; 2017 Feb; 19(2):222-234. PubMed ID: 27887865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
    Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral safety of human platelet lysate for cell therapy and regenerative medicine: Moving forward, yes, but without forgetting the past.
    Burnouf T; Barro L; Nebie O; Wu YW; Goubran H; Knutson F; Seghatchian J
    Transfus Apher Sci; 2019 Dec; 58(6):102674. PubMed ID: 31735652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human platelet lysates for human cell propagation.
    Barro L; Burnouf PA; Chou ML; Nebie O; Wu YW; Chen MS; Radosevic M; Knutson F; Burnouf T
    Platelets; 2021 Feb; 32(2):152-162. PubMed ID: 33251940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production.
    Oeller M; Laner-Plamberger S; Krisch L; Rohde E; Strunk D; Schallmoser K
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards standardized human platelet lysate production in Europe: An initiative of the European Blood Alliance.
    De Korte D; Delabie W; Feys HB; Klei T; Larsen R; Sigurjónsson Ó; Sousa AP;
    Vox Sang; 2024 Jan; 119(1):79-87. PubMed ID: 38049931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet lysate: a promising candidate in regenerative medicine.
    Meftahpour V; Malekghasemi S; Baghbanzadeh A; Aghebati-Maleki A; Pourakbari R; Fotouhi A; Aghebati-Maleki L
    Regen Med; 2021 Jan; 16(1):71-85. PubMed ID: 33543999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.
    Viau S; Chabrand L; Eap S; Lorant J; Rouger K; Goudaliez F; Sumian C; Delorme B
    PLoS One; 2017; 12(8):e0181406. PubMed ID: 28763452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Platelet Lysate as a Replacement for Fetal Bovine Serum in Limbal Stem Cell Therapy.
    Suri K; Gong HK; Yuan C; Kaufman SC
    Curr Eye Res; 2016 Oct; 41(10):1266-1273. PubMed ID: 26863375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses.
    Delila L; Wu YW; Nebie O; Widyaningrum R; Chou ML; Devos D; Burnouf T
    Platelets; 2021 Feb; 32(2):259-272. PubMed ID: 33245683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four types of human platelet lysate, including one virally inactivated by solvent-detergent, can be used to propagate Wharton jelly mesenchymal stromal cells.
    Chen MS; Wang TJ; Lin HC; Burnouf T
    N Biotechnol; 2019 Mar; 49():151-160. PubMed ID: 30465908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-virally-inactivated (Intercept-solvent/detergent) human platelet lysate for in vitro expansion of human mesenchymal stromal cells.
    Barro L; Su YT; Nebie O; Wu YW; Huang YH; Koh MB; Knutson F; Burnouf T
    Transfusion; 2019 Jun; 59(6):2061-2073. PubMed ID: 30912158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.
    Saury C; Lardenois A; Schleder C; Leroux I; Lieubeau B; David L; Charrier M; Guével L; Viau S; Delorme B; Rouger K
    Stem Cell Res Ther; 2018 May; 9(1):128. PubMed ID: 29720259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.